Charles L. Lucore

Factors Responsible for Impaired Fibrinolysis in Obese Subjects and NIDDM Patients

Janet B. McGill, David J. Schneider, Cynthia L. Arfken et al. · Diabetes · 1994 · 301 citations

Metabolic Disorder, Niddm Patients, Impaired Fibrinolysis +21

Nephrotoxicity from contrast media: attenuation with theophylline.

Richard E. Katholi, Gordon Taylor, W P McCann et al. · Radiology · 1995 · 178 citations

Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications.

Charles L. Lucore, Burton E. Sobel · Circulation · 1988 · 137 citations

Fibrinolytic Activity, Plasma Inhibitors, Immunology +19

Clopidogrel as adjunctive antiplatelet therapy during coronary stenting

Gregory Mishkel, Frank V. Aguirre, Robert W. Ligon et al. · Journal of the American College of Cardiology · 1999 · 135 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +7

Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.

Richard Eisenberg, Charles L. Lucore, Lindsay Kaufman et al. · Circulation · 1990 · 131 citations · Full text

Hypertension, Heart Failure, Pulmonary Hypertension +23